August 05, 2017

Gilead Sciences, Inc. (NASD:GILD) Zacks Rank: 2-Buy

$73.16 USD (As of 08/04/2017) Style : Value: Growth: Momentum: VGM:

Target Price $83.00 Price, Consensus & Surprise

52 Week High-Low $82.10 - $63.76
20 Day Average
8,152,420
Volume

Beta 1.21
Market Cap 95.55 B
Dividend / Div Yld $2.08 / 2.84%
Medical -
Industry
Biomed..

108 / 265 (Top

Industry Rank
41%)
Proj. EPS Growth (Q1) -23.33%
Proj. EPS Growth (F1) -25.00%

P/E (F1) 8.58

Last EPS Surprise 18.96%

Avg. Last 4 Surprises 8.18%

Next Report Date 11/7/2017

Earnings ESP 0.48%

Agreement Estimate Revisions (60 Days) Magnitude Consensus Estimate Trend (60 Days)

Q1 Q2 F1 F2 Q1 Q2 F1 F2
# of Analysts 5 5 7 7 Current 2.07 1.89 8.53 7.24

# of Revisions 3 3 5 2 7 Days Ago 2.07 1.89 8.53 7.24

# Up 3 3 5 2 30 Days Ago 1.97 1.90 7.92 7.41

# Down 0 0 0 0 60 Days Ago 1.94 1.89 7.86 7.41

Trend of
% Revision Agreement: 100% 100% 100% 100% Estimate
Revisions: +6.70% 0% +8.52% -2.29%

Industry Comparison Medical - Biomed.. | Position in Industry: 6 of 246 Industry Peers

GILD X Industry S&P 500 AMGN BIIB CELG

Hist. EPS Growth (3-5 yrs) 66.23% 19.51% 7.16% 16.08% 32.03% 23.89%
Proj. Sales Growth (F1/F0) -14.84% 0.00% 5.19% -0.78% 3.67% 18.09%
Net Margin 42.90% -293.48% 9.92% 35.46% 28.10% 21.35%
Return on Equity 66.07% -58.53% 15.95% 29.85% 37.42% 68.51%
Debt/Capital 55.72% 0.00% 41.54% 51.44% 33.97% 62.01%
P/E (F1) 8.72 25.75 18.89 13.93 13.36 20.36
Price/Sales (P/S) 3.41 13.12 2.50 5.51 5.16 8.72
Price/Book (P/B) 4.21 3.44 3.22 4.01 5.23 12.59
Price/Cash Flow (P/CF) 5.81 22.38 13.54 11.88 12.19 22.70
YTD % Price Change 3.85% 2.43% 9.77% 19.13% 0.89% 17.41%

Description Medical > Drugs > Medical - Biomedical And Genetics

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the
people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases,
including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal
drug delivery technology, a technology that the company uses to develop drugs that are safer, easier for patients to tolerate and more
effective.

Learn More about Zacks Rank and Style Scores